Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1612-9067
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3) ; day:10 ; month:11 ; year:2020 ; pages:1-10
Esophagus ; (10.11.2020), 1-10
- Urheber
-
Takahashi, Masanobu
Kato, Ken
Okada, Morihito
Chin, Keisho
Kadowaki, Shigenori
Hamamoto, Yasuo
Doki, Yuichiro
Kubota, Yutaro
Kawakami, Hisato
Ogata, Takashi
Hara, Hiroki
Muto, Manabu
Nakashima, Yuichiro
Ishihara, Ryu
Tsuda, Masahiro
Motoyama, Satoru
Kodani, Mamoru
Kitagawa, Yuko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10388-020-00794-x
- URN
-
urn:nbn:de:101:1-2020122120580072604493
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Takahashi, Masanobu
- Kato, Ken
- Okada, Morihito
- Chin, Keisho
- Kadowaki, Shigenori
- Hamamoto, Yasuo
- Doki, Yuichiro
- Kubota, Yutaro
- Kawakami, Hisato
- Ogata, Takashi
- Hara, Hiroki
- Muto, Manabu
- Nakashima, Yuichiro
- Ishihara, Ryu
- Tsuda, Masahiro
- Motoyama, Satoru
- Kodani, Mamoru
- Kitagawa, Yuko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3
Current management strategies for visceral artery aneurysms: an overview
Correction to: Current management strategies for visceral artery aneurysms: an overview
Hereditary pancreatic cancer
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3
Current management strategies for visceral artery aneurysms: an overview
Correction to: Current management strategies for visceral artery aneurysms: an overview
Hereditary pancreatic cancer
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3
Current management strategies for visceral artery aneurysms: an overview
Correction to: Current management strategies for visceral artery aneurysms: an overview
Hereditary pancreatic cancer
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma